SecSonar.com

Smith & Nephew plc (SNN)

Smith & Nephew plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Smith & Nephew plc (SNN) is a Medical - Devices company based in GB with a market capitalization of $12.7B. Revenue grew 6.3% year-over-year and the company generated $854M in free cash flow. This page tracks SNN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 17.35K employees · IPO Nov 16, 1999

Valuation

Valuation & price

$29.54 · as of May 17, 2026 · -23.7% vs 52w high

20.6

P/E ratio

Latest-FY diluted EPS

2.40

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$38.70$34.02$29.33Jul 25Dec 25Jul 26Jul 7, 25$29.94Jul 9, 25$30.69Jul 11, 25$30.28Jul 15, 25$29.33Jul 17, 25$29.88Jul 21, 25$30.28Jul 23, 25$31.84Jul 25, 25$31.67Jul 29, 25$31.60Jul 31, 25$30.56Aug 4, 25$30.79Aug 6, 25$35.50Aug 11, 25$35.96Aug 13, 25$36.78Aug 15, 25$36.20Aug 19, 25$36.88Aug 21, 25$36.97Aug 25, 25$37.15Aug 27, 25$37.25Aug 29, 25$37.45Sep 3, 25$37.35Sep 5, 25$38.09Sep 9, 25$38.70Sep 11, 25$38.53Sep 16, 25$37.39Sep 18, 25$37.03Sep 22, 25$36.52Sep 24, 25$35.84Sep 26, 25$35.42Sep 30, 25$36.29Oct 2, 25$36.45Oct 6, 25$35.91Oct 8, 25$35.93Oct 10, 25$35.11Oct 14, 25$35.26Oct 16, 25$35.81Oct 21, 25$36.53Oct 23, 25$36.49Oct 27, 25$36.68Oct 29, 25$35.78Oct 31, 25$36.82Nov 4, 25$37.02Nov 6, 25$32.45Nov 10, 25$33.35Nov 12, 25$33.47Nov 14, 25$32.69Nov 18, 25$32.54Nov 20, 25$31.99Nov 25, 25$33.42Nov 28, 25$33.28Dec 2, 25$32.44Dec 4, 25$32.73Dec 8, 25$33.49Dec 10, 25$33.44Dec 12, 25$32.63Dec 16, 25$32.31Dec 18, 25$32.70Dec 22, 25$33.12Dec 24, 25$32.84Dec 29, 25$33.14Jan 2, 26$32.88Jan 6, 26$33.90Jan 8, 26$34.16Jan 12, 26$33.68Jan 14, 26$32.92Jan 16, 26$32.70Jan 21, 26$32.78Jan 23, 26$33.31Jan 27, 26$34.08Jan 29, 26$33.66Feb 2, 26$34.26Feb 4, 26$35.09Feb 9, 26$35.06Feb 11, 26$35.30Feb 13, 26$36.18Feb 18, 26$36.26Feb 20, 26$36.13Feb 24, 26$35.97Feb 26, 26$36.68Mar 2, 26$35.76Mar 4, 26$36.36Mar 6, 26$34.31Mar 10, 26$33.07Mar 12, 26$33.04Mar 17, 26$33.37Mar 19, 26$32.34Mar 23, 26$31.94Mar 25, 26$32.45Mar 27, 26$31.64Mar 31, 26$31.78Apr 2, 26$32.14Apr 7, 26$31.73Apr 9, 26$33.13Apr 13, 26$34.00Apr 15, 26$34.22Apr 17, 26$34.36Apr 22, 26$32.74Apr 24, 26$31.57Apr 28, 26$31.08Apr 30, 26$30.93May 4, 26$30.90May 6, 26$30.26May 8, 26$29.95May 12, 26$30.06May 14, 26$29.72May 18, 26$30.30May 20, 26$31.01May 22, 26$30.53May 28, 26$29.77Jun 1, 26$29.48Jun 3, 26$29.93Jun 5, 26$30.61Jun 9, 26$31.32Jun 11, 26$30.67Jun 15, 26$30.46Jun 17, 26$30.07Jun 22, 26$29.39Jun 24, 26$30.26Jun 26, 26$30.04Jul 2, 26$30.25
$28.7352-week range$38.70
Loading valuation history…

Fundamentals

Key fundamentals

$12.7B

Market cap

6.3%

Revenue growth (YoY)

68.0%

Gross margin

$854M

Free cash flow (USD)

$2.8B

Net debt

-1.1%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$4.7BFY 2017$4.8BFY 2018$4.9BFY 2019$5.1BFY 2020$4.6BFY 2021$5.2BFY 2022$5.2BFY 2023$5.5BFY 2024$5.8BFY 2025$6.2B
$4.7B$6.2B

Free cash flow by year

2016 → 2025

FY 2016$457.0MFY 2017$714.0MFY 2018$584.0MFY 2019$760.0MFY 2020$492.0MFY 2021$469.0MFY 2022$110.0MFY 2023$181.0MFY 2024$606.0MFY 2025$854.0M
$457M$854M

Gross margin by year

2021 → 2025

FY 202170.4%FY 202270.5%FY 202368.8%FY 202469.6%FY 202568.0%
70.4%68.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingBlock Admission ApplicationJul 2, 2026Filing
  • 6-K filingTotal Voting RightsJul 1, 2026Filing
  • 6-K filingNotification of Major HoldingsJun 30, 2026Filing
  • 6-K filingMajor Holdings NotificationJun 26, 2026Filing
  • 6-K filingNotification of Major HoldingsJun 17, 2026Filing
  • 6-K filingMajor Holdings NotificationJun 11, 2026Filing
  • 6-K filingDirector Shareholding NotificationJun 4, 2026Filing
  • 6-K filingAdmission to TradingJun 3, 2026Filing
  • 6-K filingDirector Shareholding NotificationJun 3, 2026Filing
  • 6-K filingTotal Voting RightsJun 1, 2026Filing

Questions

Frequently asked questions

What is Smith & Nephew plc's market cap?

Smith & Nephew plc (SNN) has a market capitalization of $12.7B.

What is SNN's P/E ratio?

SNN trades at a price-to-earnings ratio of 20.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is SNN's price-to-book (P/B) ratio?

SNN trades at 2.40 times book value per share.

Are insiders buying SNN stock?

SEC Form 4 filings show no open-market insider buys at Smith & Nephew plc in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

ALGN

Align Technology, Inc.

$12.6B

PEN

Penumbra, Inc.

$12.5B

GMED

Globus Medical, Inc.

$11.1B

PODD

Insulet Corporation

$9.9B

ZBH

Zimmer Biomet Holdings, Inc.

$16B

MASI

Masimo Corporation

$9.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.